Netherlands-based investment firm Gilde Healthcare closed a €200m ($225m) private equity fund yesterday with a contribution from financial services firm Rabobank’s Rabo Corporate Investments unit.
Pension fund PGGM/Pensioenfonds Zorg en Welzijn has also backed the fund, as have a range of unnamed Netherlands-based institutional investors and international funds-of-funds. The fund, Gilde Healthcare Services III, closed at its hard cap.
Gilde Healthcare Services III will target healthcare and service providers as well as medical product suppliers, focusing on profitable businesses with earnings before interest, tax, depreciation and amortisation of $2.2m to $16.8m.
The vehicle will particularly seek out opportunities in Belgium, the Netherlands and Luxembourg, an economic region known as Benelux, and Germany, Austria and Switzerland, which are also known as Dach countries.
Gilde Healthcare Services III will operate out of offices in Utrecht, in the Netherlands and Frankfurt, in Germany. Apart from capital, it will offer portfolio companies access to its international network and support with growth strategies.
The firm now has more than $1.1bn under management across its three healthcare-focused funds. Jasper van Gorp, managing partner at Gilde Healthcare, said: “We are pleased with the high level of interest for our new fund which is testament to our investment strategy and track record.
“We see a strong deal flow of healthcare providers, suppliers of medical products and service providers in the Benelux and Dach regions. Via our local presence we are well-positioned to source proprietary healthcare transactions in the lower mid-market.”
